BDR Pharmaceuticals International Pvt Ltd and BDR Life sciences Pvt. Ltd, comprising of API and formulation manufacturing, focuses on development in 4 specialized therapeutic segments such as Oncology, Critical care, Gynecology & Neurology.
基于这些贸易数据,我们从贸易伙伴、进出口港、采供国、HS编码、联系方式等维度对数据进行统计汇总,这可以帮助您提高使用外贸数据的效率。上图是bdr pharmaceuticals international pvt ltd.公司近一年的市场趋势分析图,可以从交易数量、重量、价格、交易次数不同维度的趋势来了解当前公司的采供周期和业务稳定性。
BDR Pharmaceuticals International PVT. LTD. Country:India Business Type: Mr.Trushit Mehta Tel: +91-22-40560560 Mobile: Tel:+91-22-40560560 Fax:+91-22-40560560 Province/state: City: Street:BDR Pharmaceuticals International PVT. LTD. 407/408 Sharda Chambers, 15 New Marine Lines, Mumbai-400020...
Menarini Industrie Farmaceutiche Riunite Srl, AB Science SA, AdvaCare Pharma, BDR Pharmaceuticals Internationals Pvt. Ltd, Blueprint Medicines Corp., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., NOVA PHARMA LLC, ...
Pharmaceutical Others BDR Pharmaceuticals International PVT. LTD. Country:India Business Type: Mr.Trushit Mehta Tel: +91-22-40560560 Mobile: Tel:+91-22-40560560 Fax:+91-22-40560560 Province/state: City: Street:BDR Pharmaceuticals International PVT. LTD. 407/408 Sharda Chambers, 15 New Marine Li...
The group is complemented majorly by its two companies - BDR Pharmaceuticals International Pvt Ltd and BDR Life Sciences Pvt. Ltd, each one having stamped its own supremacy in respective fields, i.e. API and formulation manufacturing, respectively. BDR Group focuses on development in 6 specialized...
bdr pharmaceuticals international pvt ltd and bdr life sciences pvt. ltd, comprising of api and 展示更多全球排名 #4,835,0922,727,951 國家/地區排名 #321,403168,506 印度 同類排名 #353205 健康> 生物技術和製藥(在 印度 中) 顯示Similarweb 的估計資料。透過連接你的 GA4 公開驗證你網站的指標Google ...
City: Street:BDR Pharmaceuticals International PVT. LTD. 407/408 Sharda Chambers, 15 New Marine Lines, Mumbai-400020.India MaxCard: Nebivolol hydrochlorideCAS NO.: 152520-56-4 IrbesartanCAS NO.: 138402-11-6 EtoricoxibCAS NO.: 202409-33-4 ...